Pharma bosses call for higher drug prices in EU to counter tariff threat

Health groups hit back at 'opportunistic' pharma lobbying

NGOs says pharma threats to leave the EU are little more than a ploy to push long-standing demands for tougher intellectual property rights and deregulation.

Economist Stephen Moore: China and the EU need to pay their fair share

Economist and Unleash Prosperity Co-Founder Stephen Moore blasts China for stealing our technology, vaccines, and inventions. “Other countries do that too by the way, and that’s just not fair. I mean, the Europeans, they don’t pay their fair share of the drug cost when we invent new drugs,” he points out. “So we got to get tough with these countries and say, ‘Pay your fair share’.”

Pharmaceutical companies have announced investments of 150 billion in the United States after the tariffs, write the CEOs of Sanofi and Novartis. According to Astrazeneca, “The EU has increased defense spending, now it must support its health sovereignty.”

Sanofi Posts Strong Earnings as Dupixent Demand Keeps Growing

Sanofi SA reported better-than-expected profit in the first quarter, boosted by strong demand for its blockbuster skin and asthma drug Dupixent.

Drug firm bosses call for price increases in Europe amid tariff uncertainty

The boss of AstraZeneca said Europe should increase spending on health treatment in line with recent commitments on defence.

Novartis and Sanofi call for higher drug prices in Europe

Swiss and French pharmaceutical companies Novartis and Sanofi argue that the EU should adjust its drug prices to better align with those in the US.